What You Should Know:
- SURGE Therapeutics (SURGE) recently announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute.
- The funds will be used to accelerate the development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel.
Using
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
RLDatix to Acquire Porzio Life Sciences
What You Should Know:
- RLDatix, the leading global provider of healthcare operations software and services that drive safer care has entered into a definitive agreement to acquire Porzio Life Sciences, a market leader in compliance solutions for the life sciences industry which had been a wholly-owned subsidiary of the law firm of Porzio, Bromberg & Newman since 2004.
- Porzio Life Sciences simplifies compliance by combining its regulatory expertise with product innovation to
Read More
Eclipse and Mayo Clinic Create Nucleus RadioPharma for Cancer Patients
What You Should Know:
- Eclipse, a venture capital firm investing in the digital transformation of the world's physical industries, and Mayo Clinic, a leading nonprofit health organization, recently announced the creation and seed funding of Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new
Read More
Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research
What You Should Know:
- Obatala Sciences, a New Orleans biotechnology company recognized for speeding up therapies for obesity, diabetes, and cancer across diverse populations, recently announced the closing of a $3 million Series A finance round co-led by être Venture Capital and Ochsner Lafayette General Healthcare Innovation Fund II and joined by Benson Capital Partners, Elevate Capital Fund, and The Hackett-Robertson-Tobe Group.
- The funding will be used to further the
Read More
ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics
What You Should Know:
- ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The company will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. Its close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions it to research and develop
Read More
Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-omics
What You Should Know:
- Pleno, Inc, a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research raises $40M in Series A funding led by Deerfield Management and Foresite Capital.
- The funding will accelerate the development of Pleno’s Hypercoding™ instrument platform, called RAPTOR ™, which is slated for early customer access in 2023 and full availability in 2024. Release below
Read More
The Botched COVID-19 Response and What We Can Learn from It
The COVID-19 pandemic has completely transformed the World Order and exposed striking realities of the global healthcare infrastructure by revealing the tendencies of various countries to deal with public healthcare emergencies. It has further raised the curtain on global hegemons like the U.S.A., which lacked the capacity and finances to counter this disaster. This has intensified the need for reforms and strong legislation to mitigate the pandemic’s devastation on healthcare facilities.
Read More
Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals
What You Should Know:
- In a recent patient-centric survey, SubjectWell found that accommodations for all patients, including free treatment and study compensation, increase interest in clinical trial participation – particularly for patients of color.
- However, overall, using value-based messaging, adding education to the recruiting process and reducing friction to participation – are universally impactful, not just for diverse populations, and that certain barriers
Read More
Study Confirms mRNA Vaccines Protect Against COVID-19 During Pregnancy
What You Should Know:
- The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy
- Pregnant women were excluded from COVID-19 mRNA vaccine clinical trials, so this new study fills a significant knowledge gap, providing strong evidence that
Read More
Tavros Therapeutics Raises $7.5M to Develop Targeted Cancer Therapies
What You Should Know:
- Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments.
- Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More
